Show simple item record

Management Practices for Methicillin-Resistant Bacteremia by Adult Infectious Diseases Physicians.

dc.contributor.authorBanniettis, Natalie
dc.contributor.authorBeekmann, Susan E
dc.contributor.authorPolgreen, Philip M
dc.contributor.authorKaushik, Shubhi
dc.contributor.authorKohlhoff, Stephan
dc.contributor.authorGilbert, David
dc.contributor.authorBennett, John E
dc.contributor.authorHammerschlag, Margaret R
dc.date.accessioned2023-07-07T16:56:41Z
dc.date.available2023-07-07T16:56:41Z
dc.date.issued2018-05-19
dc.identifier.citationBanniettis N, Beekmann SE, Polgreen PM, Kaushik S, Kohlhoff S, Gilbert D, Bennett JE, Hammerschlag MR. Management Practices for Methicillin-Resistant Staphylococcus aureus Bacteremia by Adult Infectious Diseases Physicians. Open Forum Infect Dis. 2018 May 19;5(5):ofy093. doi: 10.1093/ofid/ofy093. PMID: 29876367; PMCID: PMC5961149.en_US
dc.identifier.issn2328-8957
dc.identifier.doi10.1093/ofid/ofy093
dc.identifier.pmid29876367
dc.identifier.urihttp://hdl.handle.net/20.500.12648/10407
dc.description.abstractTo assess current use of vancomycin for methicillin-resistant bacteremia, we surveyed adult infectious disease physicians. Most respondents reported personal experience with infections failing to respond to vancomycin despite minimum inhibitory concentration data indicating susceptibility. In a hypothetical case of such an infection, most would change to daptomycin with or without other agents.
dc.language.isoenen_US
dc.relation.urlhttps://academic.oup.com/ofid/article/5/5/ofy093/4999943?login=falseen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectGSSAen_US
dc.subjectMRSAen_US
dc.subjectbacteremiaen_US
dc.subjecttreatment failureen_US
dc.subjectvancomycinen_US
dc.titleManagement Practices for Methicillin-Resistant Bacteremia by Adult Infectious Diseases Physicians.en_US
dc.typeArticle/Reviewen_US
dc.source.journaltitleOpen forum infectious diseasesen_US
dc.source.volume5
dc.source.issue5
dc.source.beginpageofy093
dc.source.endpage
dc.source.countryUnited States
dc.description.versionVoRen_US
refterms.dateFOA2023-07-07T16:56:41Z
html.description.abstractTo assess current use of vancomycin for methicillin-resistant bacteremia, we surveyed adult infectious disease physicians. Most respondents reported personal experience with infections failing to respond to vancomycin despite minimum inhibitory concentration data indicating susceptibility. In a hypothetical case of such an infection, most would change to daptomycin with or without other agents.
dc.description.institutionSUNY Downstateen_US
dc.description.departmentPediatricsen_US
dc.description.degreelevelN/Aen_US
dc.identifier.journalOpen forum infectious diseases
dc.identifier.issue5en_US


Files in this item

Thumbnail
Name:
ofy093.pdf
Size:
136.1Kb
Format:
PDF
Download

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International